[This Week's IPO] Book-Building and Subscription Schedule for the Third Week of November

In the third week of this month (November), Samjin Food, Pescaro, Livsmed, TMC, and Aegis will conduct book-building for institutional investors. Aromatica and AimedBio are preparing for their general subscription periods.

<Book-Building>

◆Samjin Food = Founded in 1953 at Jagalchi Market in Busan, Samjin Food is a leading seafood processing company that has spearheaded Korea's fish cake industry for over 70 years. The company has transformed fish cakes from a traditional ingredient into a premium food and K-Food brand, leading the paradigm shift toward the "branding of the fish cake industry."

The company plans to offer 2 million new shares. The desired offering price per share is between 6,700 and 7,600 won, with a total expected offering amount of approximately 13.4 billion to 15.2 billion won. The book-building for institutional investors will take place from November 19 to 25, and the general subscription will be held on December 1 and 2. Daishin Securities is the lead underwriter.

◆Pescaro = Established in 2016, Pescaro is a vehicle integrated security platform company founded by automotive electronics system experts and former white-hat hackers. By building a comprehensive security system that covers not just controller-level solutions but the entire vehicle system and lifecycle, the company has secured a differentiated competitive edge.

The company plans to offer a total of 1.3 million shares. The desired offering price is between 12,500 and 15,500 won per share, with an expected offering amount of 16.2 billion to 20.1 billion won. Book-building for institutional investors will be conducted over five days from November 21 to 27, and the general subscription will take place on December 1 and 2, with the goal of listing on KOSDAQ within the year. NH Investment & Securities is the lead underwriter, with Hanwha Investment & Securities as co-manager.

◆Livsmed = Livsmed is the only company with an integrated portfolio covering the entire minimally invasive surgery process, including Artisential, Artiseal, ArtiStapler (surgical stapler), LivsCam (laparoscopic camera system), and Stark (surgical robot).

The company will offer a total of 2.47 million shares, with a desired offering price band of 44,000 to 55,000 won per share and an expected offering amount of approximately 108.7 billion to 135.9 billion won. After book-building in November and the general subscription in December, the company aims to list on KOSDAQ within the year. Samsung Securities and Mirae Asset Securities are co-lead underwriters.

◆TMC = Founded in 1991, TMC manufactures industrial specialty cables for shipbuilding and marine, optical cables, and nuclear power, based on the largest production capacity in Korea. As the market leader in cable supply to the nation's top three shipbuilders-Samsung Heavy Industries, Hanwha Ocean, and HD Korea Shipbuilding & Offshore Engineering-the company recorded an average annual sales growth rate of 8.8% from 2022 to 2024, maintaining steady growth.

The company will offer a total of 6.1 million shares. The offering price band is 8,000 to 9,300 won per share, resulting in a total expected offering amount of 48.8 billion to 56.7 billion won. Book-building will take place from November 21 to 27, and the general subscription will be held on December 3 and 4. Mirae Asset Securities is the lead underwriter.

◆Aegis = Established in 2001, Aegis is a 3D geographic information system (GIS)-based digital earth platform company. It is the only company in Korea to provide full-cycle services for the digital earth ecosystem and has devoted over 20 years to developing 3D GIS technology.

The company will offer a total of 1.5 million shares, with a desired offering price of 13,000 to 15,000 won per share. Book-building for institutional investors will be held from November 21 to 27, and the general subscription will take place on December 2 and 3. NH Investment & Securities is the lead underwriter.

<General Subscription>

◆Aromatica = The desired offering price band is 6,000 to 8,000 won per share, resulting in a total expected offering amount of 18 billion to 24 billion won. Book-building was completed by November 13, and the general subscription will be held on November 18 and 19. Shinhan Investment & Securities is the lead underwriter.

Aromatica is recognized as a leading company in the conscious beauty sector in Korea, having introduced EWG cosmetic ingredients for the first time in the country and pioneered organic and vegan cosmetics. The company is also known for promoting sustainability through packaging design, reuse, and recycling culture.

◆AimedBio = The desired offering price is 9,000 to 11,000 won per share, and book-building will continue until November 18. The general subscription will take place from November 21 to 24, after which the company aims to list on KOSDAQ. Mirae Asset Securities is the lead underwriter.

AimedBio was spun off from Samsung Medical Center in 2018 and has established an ADC new drug development platform based on unmet clinical needs. Leveraging this, the company is developing a pipeline with enhanced clinical predictability and applicability.

This content was produced with the assistance of AI translation services.